Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
SMMT — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

21.71

Margin Of Safety %

Put/Call OI Ratio

0.51

EPS Next Q Diff

-0.03

EPS Last/This Y

0.63

EPS This/Next Y

-0.05

Price

16.62

Target Price

28.51

Analyst Recom

1.94

Performance Q

3.29

Upside

-225.2%

Beta

-1.3

Ticker: SMMT



22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23SMMT22.270.503.1799284
2026-04-24SMMT22.080.550.69107065
2026-04-27SMMT22.130.590.67105821
2026-04-28SMMT21.250.600.73109568
2026-04-29SMMT20.810.610.98110931
2026-04-30SMMT21.450.620.40112415
2026-05-01SMMT16.120.600.47117228
2026-05-04SMMT16.980.480.26121543
2026-05-05SMMT17.530.480.59138494
2026-05-06SMMT17.830.480.17147490
2026-05-07SMMT17.130.460.17154898
2026-05-08SMMT18.090.450.13157147
2026-05-11SMMT18.670.420.24160555
2026-05-12SMMT18.950.420.22163319
2026-05-13SMMT18.790.428.01163969
2026-05-14SMMT18.130.460.26168979
2026-05-15SMMT16.880.451.75168921
2026-05-18SMMT16.010.450.31164174
2026-05-19SMMT15.860.420.04171689
2026-05-20SMMT17.90.470.36162893
2026-05-21SMMT17.490.482.99167414
2026-05-22SMMT16.620.510.67167380
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1



22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23SMMT22.26-204.3559.1-0.88
2026-04-24SMMT22.09-204.3563.1-0.88
2026-04-27SMMT22.13-204.3562.3-0.88
2026-04-28SMMT21.25-204.3583.6-0.88
2026-04-29SMMT20.82-204.3594.3-0.88
2026-04-30SMMT21.46-204.3578.6-0.88
2026-05-01SMMT16.11-204.3708.8-0.88
2026-05-04SMMT16.98-204.3- -0.88
2026-05-05SMMT17.5475.9- -0.89
2026-05-06SMMT17.8475.9- -0.89
2026-05-07SMMT17.1462.6- -0.81
2026-05-08SMMT18.0962.6- -0.81
2026-05-11SMMT18.6762.6- -0.81
2026-05-12SMMT18.9564.0- -0.81
2026-05-13SMMT18.7864.0- -0.81
2026-05-14SMMT18.1462.6- -0.79
2026-05-15SMMT16.8762.6- -0.79
2026-05-18SMMT16.0162.6- -0.79
2026-05-19SMMT15.8562.6- -0.79
2026-05-20SMMT17.9062.6- -0.81
2026-05-21SMMT17.4862.6- -0.81
2026-05-22SMMT16.6262.6- -0.81
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1



22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23SMMT0.0912.1125.81
2026-04-24SMMT0.0012.1125.81
2026-04-27SMMT0.0012.1125.77
2026-04-28SMMT0.0012.1125.77
2026-04-29SMMT0.0012.1125.77
2026-04-30SMMT0.0012.1125.77
2026-05-01SMMT0.0012.1125.77
2026-05-04SMMT0.0011.9225.77
2026-05-05SMMT0.0011.9225.77
2026-05-06SMMT0.0011.9225.77
2026-05-07SMMT0.0011.9225.77
2026-05-08SMMT0.0011.9225.77
2026-05-11SMMT0.0011.9925.77
2026-05-12SMMT0.0011.9921.80
2026-05-13SMMT0.0011.9921.80
2026-05-14SMMT0.0011.9921.80
2026-05-15SMMT0.0011.9921.80
2026-05-18SMMT0.0011.3521.71
2026-05-19SMMT0.0011.3521.71
2026-05-20SMMT0.0011.3521.71
2026-05-21SMMT0.0011.3521.71
2026-05-22SMMT0.0011.3521.71
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS​

-0.18

Avg. EPS Est. Current Quarter

-0.21

Avg. EPS Est. Next Quarter

-0.21

Insider Transactions

Institutional Transactions

11.35

Beta

-1.3

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

4

Growth Score

22

Sentiment Score

15

Actual DrawDown %

55

Max Drawdown 5-Year %

-92

Target Price

28.51

P/E

Forward P/E

PEG

P/S

P/B

23.62

P/Free Cash Flow

EPS

-1.6

Average EPS Est. Cur. Y​

-0.81

EPS Next Y. (Est.)

-0.86

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

2

Return on Equity vs Sector %

-248

Return on Equity vs Industry %

-232.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.07

EBIT Estimation

◆ SMMT Healthcare
$16.62
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
16/25
Volume
3/15
Valuation
12/20
TP/AR
1/10
Options
4/10
RSI
42
Range 1M
16.1%
🚀
Momentum Growth
Ride accelerating trends
N/A
36 /100
WEAK
Momentum
13/25
Growth
9/30
Estimates
0/20
Inst/Vol
9/15
Options
5/10
EPS Yr
21.5%
EPS NY
-1.2%
52W%
16.6%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +71.5% upside
Quality
2/30
Valuation
12/30
Growth
7/25
Stability
7/10
LT Trend
4/5
Upside
+71.5%
Quality
4
Click a card to see score breakdown Full Analysis →
Summit Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 265
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.
SMMT

Latest News

—
Caricamento notizie per SMMT…
stock quote shares SMMT – Summit Therapeutics Inc Stock Price stock today
news today SMMT – Summit Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch SMMT – Summit Therapeutics Inc yahoo finance google finance
stock history SMMT – Summit Therapeutics Inc invest stock market
stock prices SMMT premarket after hours
ticker SMMT fair value insiders trading